IFA Capital Management, A New Hedge Fund Launched by Life Science Veterans, Taps Rho Impact for Sustainability Data & Tools
Charlottesville, VA – January 1st, 2026 – IFA Capital Management, LLC., a newly launched investment firm founded by life sciences industry veterans Kellie Seringer and Matt Johnson, today announced a strategic collaboration with Rho Impact, a leader in climate impact forecasting and advanced data solutions, to support its concentrated investment approach in the life sciences sector. Rho will serve as IFA Capital’s sustainability technology partner by delivering Koi, the world's most comprehensive data platform for assessing the impact potential of emerging sustainability solutions and their associated market opportunities. This collaboration strengthens the fund’s ability to evaluate investments in low-carbon, industry-specific solutions.
According to research from the National Center for Biotechnology Information, laboratories consume more energy per square meter than any other sector. As climate regulations go into effect in major markets around the world, this collaboration helps IFA Capital identify companies that deliver superior market value and clinical outcomes with less energy, materials, and emissions compared to conventional offerings on the market. As the world transitions to a low-carbon economy, IFA Capital will leverage Koi to invest in the most promising medical breakthroughs.
The IFA team’s collective experience provides capital allocators the opportunity to advance medical innovation for a low-carbon economy. “Sustainability is becoming a measurable marker of company quality in life sciences – enhancing R&D efficiency, de-risking operations and strengthening market positioning – while driving valuation premiums at M&A and IPO inflection points,” said Kellie Seringer, Co-Founder and Portfolio Manager at IFA Capital. “Our collaboration with Rho Impact embeds sustainability into our due diligence and equips portfolio companies to build higher-quality, future-ready operations that resonate with investors and leading pharmaceutical acquirers.”
“Rho Impact is thrilled to partner with IFA Capital to accelerate sustainable innovation in a critical global sector,” said Noah Miller, Co-Founder & Chief Advisory Officer of Rho Impact. “As governments around the world set decarbonization goals for their healthcare systems, we believe IFA Capital will have a critical role to play in identifying, funding, and scaling the most impactful solutions in life sciences. We are beyond proud to support IFA Capital’s important efforts.”
About IFA Capital Management, LLC
IFA Capital Management, LLC is a specialized investment management firm dedicated to the life sciences sector. Led by founding principals Kellie Seringer and Matt Johnson—who bring over 50 years of combined experience across healthcare capital markets and clinical operations—the firm applies a disciplined, research-intensive framework to the biotechnology landscape.